Skip to main content
. 2019 Oct 31;10:1145. doi: 10.3389/fneur.2019.01145

Table 2.

Caretakers' perception of improvement in each symptom category.

Case # Months of CE treatment# Perception of improvement of symptoms (%)*
ADHD BD MD AD CSID CD SD SZ**
01f 09 15 15 - 10 15 15 50 -
02m 06 40 10 20 30 60 40 40 -
03m 09 40 30 40 20 40 30 50 -
04m 15 30 20 20 10 40 30 30 -
05f 27 50 25 35 20 25 35 40 -
06m 09 30 00 - 00 00 20 - -
07m 09 15 15 15 15 15 15 50 -
08f 09 20 20 - 10 60 20 60 -
09m 09 00 −10 20 00 00 20 - -
10m 09 30 25 20 10 30 15 - -
11m 09 85 85 10 25 30 50 60 100
12m 09 50 00 55 00 40 10 25 ≥50
13f 09 20 20 00 00 00 00 20 ≥50
14m 39 35 40 20 15 25 30 85 ≥50
15m 09 00 00 00 00 00 00 10 100
n## 15 15 12 15 15 15 12 05
Median 30 20 20 10 25 20 40 NA

ADHD, Attention Deficit/Hyperactivity Disorder; BD, Behavioral Disorders; MD, Motor Deficits; AD, Autonomy Deficits; CSID, Communication and Social Interaction Deficits; CD, Cognitive Deficits; SD, Sleep Disorders; SZ, Seizures.

f

female patients.

m

male patients.

*

Lack of improvement is computed as 00% and worsening of symptoms are recorded as negative values.

#

Total time of CE use, including before the onset of standardized CE.

##

Number of patients presenting each symptom. A dash (-) indicate lack of the symptom before treatment onset. NA, Not applicable.

**

Scores for seizures are: 00, for lack of improvement, <50%, for reduction of <50% in the occurrence of SZ, ≥50%, for reduction of more than 50% in the occurrence of SZ; or 100% for cases of complete cessation of SZ.